Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.

Yi YC, Chen MK, Chen LY, Ho ES, Ying TH, Wang PH, Yang SF.

Clin Chim Acta. 2009 Nov;409(1-2):127-31. doi: 10.1016/j.cca.2009.09.015.

PMID:
19758569
2.

Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.

Su CK, Yeh KT, Yeh CB, Wang PH, Ho ES, Chou MC, Liu KC, Yang SF, Yi YC.

J Surg Oncol. 2011 Dec;104(7):755-9. doi: 10.1002/jso.22035.

PMID:
21761413
3.

[Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].

Zhao XW, Li Y, Wang N, Zhao J, Li XL, Liu Q, Jia JH, Yang ZF, Kang S.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Jun;25(3):280-3. Chinese.

PMID:
18543216
4.

Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.

Wei JC, Lee HS, Chen WC, Shiu LJ, Yang SF, Wong RH.

Ann Rheum Dis. 2009 Nov;68(11):1781-6. doi: 10.1136/ard.2008.099481.

PMID:
19019896
5.

p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.

Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, Kang SB, Lee HP.

Gynecol Oncol. 2004 May;93(2):499-505.

PMID:
15099969
6.

Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population.

Sugimoto M, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T.

J Soc Gynecol Investig. 2006 Oct;13(7):523-9.

PMID:
16990034
7.

An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.

Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A.

Cancer Detect Prev. 2007;31(2):102-9.

PMID:
17418979
8.

Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis.

Kang S, Zhao X, Xing H, Wang N, Zhou R, Chen S, Li W, Zhao J, Duan Y, Sun D, Li Y.

Environ Mol Mutagen. 2008 Apr;49(3):226-31. doi: 10.1002/em.20375.

PMID:
18288718
9.

Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm.

Hinterseher I, Krex D, Kuhlisch E, Schmidt KG, Pilarsky C, Schneiders W, Saeger HD, Bergert H.

World J Surg. 2007 Nov;31(11):2248-54.

PMID:
17899257
10.

Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients.

Indelicato M, Chiarenza V, Libra M, Malaponte G, Bevelacqua V, Marchini M, McCubrey JA, Stivala F, Scorza R, Mazzarino MC.

J Clin Lab Anal. 2006;20(5):173-6.

PMID:
16960901
11.

Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans.

Vairaktaris E, Yapijakis C, Yiannopoulos A, Vassiliou S, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Critselis E, Avgoustidis D, Neukam FW, Patsouris E.

Oncol Rep. 2007 Apr;17(4):963-8.

PMID:
17342343
12.

The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women.

Zubor P, Stanclova A, Kajo K, Hatok J, Klobusiakova D, Visnovsky J, Danko J.

Oncology. 2009;76(3):173-83. doi: 10.1159/000201570.

PMID:
19209008
13.

Cyclin D1 polymorphism and the risk of endometrial cancer.

Kang S, Kim JW, Park NH, Song YS, Kang SB, Lee HP.

Gynecol Oncol. 2005 May;97(2):431-5.

PMID:
15863141
14.

Insulin receptor substrate-2 gene polymorphism: is it associated with endometrial cancer?

Cayan F, Tok E, Aras-Ateş N, Ayaz L, Akbay E, Gen R, Karakaş S, Dilek S.

Gynecol Endocrinol. 2010 May;26(5):378-82. doi: 10.3109/09513591003632241.

PMID:
20184486
15.

Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population.

Lee HJ, Lee GH, Nah S, Lee KH, Yang H, Kim YM, Chun W, Hong S, Kim S.

Rheumatol Int. 2008 Jul;28(9):845-50. doi: 10.1007/s00296-008-0545-4.

PMID:
18301898
16.

Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population.

Yang L, Gu HJ, Zhu HJ, Sun QM, Cong RH, Zhou B, Tang NP, Wang B.

Eur J Surg Oncol. 2008 Jun;34(6):636-41.

PMID:
17954022
17.

Estrogen receptor polymorphisms and the risk of endometrial cancer.

Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ.

BJOG. 2009 Jul;116(8):1053-61. doi: 10.1111/j.1471-0528.2009.02185.x.

18.

TIMP-2 gene polymorphism is associated with intracerebral hemorrhage.

Reuter B, Bugert P, Stroick M, Bukow S, Griebe M, Hennerici MG, Fatar M.

Cerebrovasc Dis. 2009;28(6):558-63. doi: 10.1159/000247599.

PMID:
19844095
19.

Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease.

Meijer MJ, Mieremet-Ooms MA, Sier CF, van Hogezand RA, Lamers CB, Hommes DW, Verspaget HW.

Inflamm Bowel Dis. 2009 Jan;15(1):84-92. doi: 10.1002/ibd.20581.

PMID:
18634035
20.

Significant association of genetic polymorphism of human nonmetastatic clone 23 type 1 gene with an increased risk of endometrial cancer.

Wang PH, Yi YC, Tsai HT, Tee YT, Ko JL, Han CP, Liu YF, Lin LY, Yang SF.

Gynecol Oncol. 2010 Oct;119(1):70-5. doi: 10.1016/j.ygyno.2010.06.013.

PMID:
20599259
Items per page

Supplemental Content

Support Center